ACM Research Inc vs Adaptive Biotechnologies Corp — how do they compare? ACM Research Inc trades at $83.55 (market cap $5.57B), while Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B). The key difference: ACM Research Inc is the larger of the two by market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, ACM Research Inc nearer its low. Which is the better fit depends on your goals.
| ACMR | ADPT | |
|---|---|---|
Market Cap | $5.57B | $4.04B |
Sector | Technology | Health |
52-Week High | $126.89 | $25.45 |
52-Week Low | $24.93 | $12.30 |
Enterprise Value | $4.48B | $4.10B |
Trailing returns across standard periods
ACM Research develops and manufactures semiconductor process equipment, specializing in wafer cleaning and electroplating solutions. Its tools are used by global chipmakers to improve productivity and yield for logic and memory chips.
Read more on ACMR →Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →